TASE:KMDA KAMADA - is a developer of life saving therapeutics. A global specialty plasma-derived biopharmaceutical company with a diverse portfolio of marketed products, a robust
development pipeline and industry-leading manufacturing capabilities. The Company’s strategy is focused on driving profitable growt
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1 ILS
53.53 M ILS
595.80 M ILS
31.08 M
About Kamada Ltd.
Sector
Industry
CEO
Amir London
Website
Headquarters
Rehovot
Founded
1990
ISIN
IL0010941198
FIGI
BBG000C0KFB7
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Kamada - buy sentimentPay attention to the day of February 10 when the estimated results for 2020 are announced.
If they are positive, then the price will rise to 8.90 and then the next monthly resistance from 10usd
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial
Kamada announces a development of the anti-corona drug.Kamada Provides Update on Progress Related to its Proprietary Hyper-Immunoglobulin (IgGs) Platform Technology including its Commercial Anti-Rabies IgG and its Pipeline Products Anti-Corona (COVID-19) and Anti-Zika IgGs
Rehovot, Israel, March 11, 2020 – Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of KMDA is 2,417 ILA — it has increased by 3.19% in the past 24 hours. Watch KAMADA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange KAMADA stocks are traded under the ticker KMDA.
KMDA stock has risen by 7.00% compared to the previous week, the month change is a −2.34% fall, over the last year KAMADA has showed a 26.41% increase.
We've gathered analysts' opinions on KAMADA future price: according to them, KMDA price has a max estimate of 7,367.57 ILA and a min estimate of 4,052.16 ILA. Watch KMDA chart and read a more detailed KAMADA stock forecast: see what analysts think of KAMADA and suggest that you do with its stocks.
KMDA reached its all-time high on Mar 3, 2014 with the price of 6,200 ILA, and its all-time low was 447 ILA and was reached on Dec 29, 2008. View more price dynamics on KMDA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KMDA stock is 2.46% volatile and has beta coefficient of 0.91. Track KAMADA stock price on the chart and check out the list of the most volatile stocks — is KAMADA there?
Today KAMADA has the market capitalization of 1.41 B, it has increased by 5.46% over the last week.
Yes, you can track KAMADA financials in yearly and quarterly reports right on TradingView.
KAMADA is going to release the next earnings report on May 27, 2025. Keep track of upcoming events with our Earnings Calendar.
KMDA earnings for the last quarter are 0.27 ILA per share, whereas the estimation was 0.19 ILA resulting in a 37.01% surprise. The estimated earnings for the next quarter are 0.25 ILA per share. See more details about KAMADA earnings.
KAMADA revenue for the last quarter amounts to 142.12 M ILA, despite the estimated figure of 143.73 M ILA. In the next quarter, revenue is expected to reach 157.36 M ILA.
KMDA net income for the last quarter is 14.10 M ILS, while the quarter before that showed 14.34 M ILS of net income which accounts for −1.71% change. Track more KAMADA financial stats to get the full picture.
KAMADA dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 20, 2025, the company has 420 employees. See our rating of the largest employees — is KAMADA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KAMADA EBITDA is 127.60 M ILS, and current EBITDA margin is 21.04%. See more stats in KAMADA financial statements.
Like other stocks, KMDA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KAMADA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KAMADA technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KAMADA stock shows the buy signal. See more of KAMADA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.